Professional Documents
Culture Documents
net/publication/332756405
CITATIONS READS
5 602
13 authors, including:
Some of the authors of this publication are also working on these related projects:
Design, synthesis and optimization of covalent reversible inhibitors of cysteine proteases View project
All content following this page was uploaded by Antonella Messore on 27 February 2021.
To cite this article: Daniela De Vita, Valentina Noemi Madia, Valeria Tudino, Francesco Saccoliti,
Alessandro De Leo, Antonella Messore, Patrizia Roscilli, Alfonso Botto, Ivano Pindinello, Gianluigi
Santilli, Luigi Scipione, Roberta Costi & Roberto Di Santo (2019): Comparison of different methods
for the extraction of cannabinoids from cannabis, Natural Product Research
1. Introduction
Until recently, Cannabis sativa L., (Cannabaceae) was exclusively considered as a
substance of abuse. Since its therapeutic effects have been investigated for the
Table 2. Ultrasound-assisted extraction. Values are expressed in mg/mL. The extraction was
performed with 0.5 g of plant material in 25 mL of EtOH for 50 min at 60 C.
THC TOT CBD TOT
BEDIOL (6.5 THC; 8 CBD)a 2.00 4.80
FM2 (5–8 THC; 7.5–12 CBD)a 1.90 8.10
BEDROCAN (18–22 THC; 1 CBD)a 5.60 0.10
a
The data in brackets represent the content of THC or CBD in medicinal cannabis expressed in %w/w.
As shown in Table 2, even though the total amount of THC and CBD is lower than
control, it is worthy of note that sonication allowed to extract 8.1 mg/mL of total CBD
from FM2, a content comparable to control, at milder temperature and in a more inex-
pensive, safe, environmental-friendly and energy-efficient way.
The microwave-assisted extraction (MAE) yield of the variety ‘Eletta Campana’ was
evaluated by analyzing four different parameters: time, temperature, ramping time
and solvent. As shown in Table 3, the amount of CBD increases by increasing both
time and temperature of at least 4 times under microwave conditions in respect to ref-
erence extraction. The solvent also affects the content of CBD as a better result is
obtained by using olive oil instead of ethanol with a shorter ramping time.
Noteworthy, an opposite trend of the extracted CBD-A content is observed because it
4 D. DEVITA ET AL.
Table 4. Microwave assisted extraction. Values are expressed in mg/mL. The extraction was
performed with 0.1g of plant material in 5 ml of olive oil for 3 min at 90 C, T ramping 1.4 min.
THC TOT CBD TOT
BEDIOL (6.5 THC; 8 CBD)a 1.20 2.35
FM2 (5–8 THC; 7.5–12 CBD)a 1.60 3.06
BEDROCAN (18–22 THC; 1 CBD)a 4.10 0.10
a
The data in brackets represent the content of THC or CBD in medicinal cannabis expressed in %w/w.
Also in this case, before performing the extraction, the plant material underwent
decarboxylation. As observed with industrial hemp, also for the medicinal one the UAE
proved to be more satisfactory than MAE in terms of extraction yield of both total
THC and CBD amount. Moreover, differently from UAE, the total CBD content extracted
from FM2 resulted lower than control, being 3.06 mg/mL (Table 4) instead of 8.1 mg/
mL obtained by UAE.
In Table 5 are reported the results obtained for the variety ‘Eletta Campana’
extracted with 2% solution of tween in ethanol or water. As general trend, the
NATURAL PRODUCT RESEARCH 5
3. Experimental
3.1 Materials
Industrial hemp (Eletta campana, Carmagnola selezionata) is available in the Italian
market for legal sales. The extraction of medicinal cannabis (BediolV, FM2V and
R R
procedure of industrial hemps, and analyzed for the cannabinoid titration as required
by Italian law. Certified reference solutions (1 mg/mL) of Cannabidiol (CBD),
Cannabidiolic acid (CBDA), D9-Tetrahydrocannabinol (THC), Cannabinol (CBN),
D9-Tetrahydrocannabinolic acid (THCA) were purchased from Sigma-Aldrich (Milan,
Italy). Organic solvents HPLC grade were purchased from Sigma-Aldrich (Milan, Italy)
and Carlo Erba, and used without further purification. Tween 20, MCT (medium chain
triglycerides) and olive oils, all of pharmaceutical grade, were obtained from
Farmalabor Srl. Water was purified before use by a Milli-Q plus 185 system (Milford,
MA, USA). Ultrasonic-assisted extraction was performed with an Elmasonic S 60 H
(Elmasonic) sonicator. CEM Discover Microwave was used for microwave-assisted
extraction (MAE). Method development for analysis of the extract was carried out with
a HPLC system consisting of a Shimadzu LC-10AD pump, a SIL-10AD autosampler
using a 200 lL sample loop, a CTO-10AC column oven, a SPD-10A detector. The
detector was set at 220 nm. Data analyses were performed using the LC solutions soft-
ware. The HPLC analysis were performed using an analytical column Waters Symmetry
C18 (150 mm 4.6 mm, 3.5 lm) by isocratic elution with a flow rate of 1.0 mL min1
at 30 C. The mobile phase composition was acetonitrile:water 80:20 (0.1% TFA) v/v.
The calibration curve was constructed with standard solutions of CBD-A, CBD, CBN,
THC-A and THC in ethanol ranging from 0.01 to 1 mg/mL. Peak area of each com-
pounds were plotted vs. actual concentrations. Linearity was assessed through evalu-
ation of the coefficient of determination (R2). The total CBD content, expressed as mg/
mL, is intended as the sum of CBD and (0.887 CBD-A) and the total THC content,
expressed in mg/mL, results from the sum of THC and (0.887 THC-A)
Acknowledgements
We are indebted to the pharmacists Drs. Piero Lussignoli, Adalberto Fabbriconi, Pietro Siciliano
and Mario Marcucci for providing the cannabis-based medicinal extracts and for their continued
help and valuable advice.
NATURAL PRODUCT RESEARCH 7
Disclosure statement
No potential conflict of interest was reported by the authors.
ORCID
Luigi Scipione http://orcid.org/0000-0002-2006-7005
Roberta Costi http://orcid.org/0000-0002-1314-9029
Roberto Di Santo http://orcid.org/0000-0002-4279-7666
References
Abrams DI, Guzman M. 2015. Cannabis in cancer care. Clin Pharmacol Ther. 97(6):575–586.
Badowski ME, Yanful PK. 2018. Dronabinol oral solution in the management of anorexia and
weight loss in AIDS and cancer. Ther Clin Risk Manag. 14:643–651.
Cressey D. 2015. The cannabis experiment. Nature. 524(7565):280–283.
Citti C, Ciccarella G, Braghiroli D, Parenti C, Vandelli MA, Cannazza G. 2016. Medicinal cannabis:
Principal cannabinoids concentration and their stability evaluated by a high performance
liquid chromatography coupled to diode array and quadrupole time of flight mass spectrom-
etry method. J Pharm Biomed Anal. 128:201–209.
Giacoppo S, Bramanti P, Mazzon E. 2017. Sativex in the management of multiple sclerosis-
related spasticity: an overview of the last decade of clinical evaluation. Mult Scler Relat
Disord. 17:22–31.
Fellermeier M, Eisenreich W, Bacher A, Zenk MH. 2001. Biosynthesis of cannabinoids: incorpor-
ation experiments with 13C-labeled glucoses. Eur J Biochem. 268(6):1596–1604.
Meng Q, Buchanan B, Zuccolo J, Poulin MM, Gabriele J, Baranowski DC. 2018. A reliable and vali-
dated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 con-
sumer products. PLoS One. 13(5):e0196396.
Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M. 2018. The
use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic
review of reviews. Curr Neurol Neurosci Rep. 18(2):8.
Romano LL, Hazekamp A. 2013. Cannabis oil: chemical evaluation of an upcoming cannabis-
based medicine. Cannabinoids. 1(1):1–11.
Russo EB. 2011. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid
entourage effects. Br J Pharmacol. 163(7):1344–1364.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S,
Misso K, Ryder S, et al. 2015. Cannabinoids for medical use: a systematic review and meta-
analysis. JAMA. 313(24):2456–2473.